Estrogens in Men: Clinical Implications for Sexual Function and the Treatment of Testosterone Deficiency

Journal of Sexual Medicine

Volumn 9, Issue 6, 2012, Pages 1681-1696

  Kacker, Ravi ^a   Traish, Abdulmaged M ^b   Morgentaler, Abraham ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aromatase inhibitors; Estrogen; Estrogen and male sexual function; Hypogonadism; Testosterone deficiency; Testosterone therapy

Indexed keywords

ANASTROZOLE; CLOMIFENE CITRATE; ESTROGEN; LUTEINIZING HORMONE; TESTOSTERONE;

ANDROGEN DEFICIENCY; ANDROGEN THERAPY; CASTRATED MALE; ESTROGEN BLOOD LEVEL; HUMAN; PRIORITY JOURNAL; REVIEW; SEXUAL FUNCTION; SEXUALITY; TESTOSTERONE BLOOD LEVEL;

EID: 84861815539     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2012.02726.x     Document Type: Article

References (116)

1. Sharpe RM. Do males rely on female hormones? Nature 1997;390:447-8.
2. Mechoulam R, Brueggmeier RW, Denlinger DL. Estrogens in insects. Cell Mol Life Sci 1984;40:942-4.
3. Ryan KJ. Biochemistry of aromatase: Significance to female reproductive physiology. Cancer Res 1982;42:3342s-4s.
4. O'Donnell L, Robertson KM, Jones ME, Simpson ER. Estrogen and seprmatogenesis. Endocr Rev 2001;22:289-318.
5. Labrie F, Belanger A, Cusan L, Gomez JL, Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 1997;82:2396-402.
6. Boothby L. Bioidentical hormone therapy: A review. Menopause 2004;11:356-67.
7. Grow DR. Metabolism of endogenous and exogenous reproductive hormones. Obstet Gynecol Clin North Am 2002;29:425-36.
8. Saez JM, Morera AM, Dazard A, Bertrand J. Adrenal and testicular contribution to plasma oestrogens. J Endocrinol 1972;55:41-4.
9. Ishikawa T, Glidewell-Kenny C, Jameson JL. Aromatase-independent testosterone conversion into estrogenic steroids is inhibited by a 5α-reductase inhibitor. J Steroid Biochem Mol Biol 2006;98:133-8.
10. Nilsson S, Gustafsson JA. Estrogen receptors: Therapies targeted to receptor subtypes. Clin Pharmacol Ther 2011;89:44-5.
11. Mowa CN, Jesmin S, Miyauchi T. The penis: A new target and source of estrogen in male reproduction. Histol Histopathol 2006;21:53-67.
12. Saunders PT, Sharpe RM, Williams K, Macpherson S, Urquart H, Irvine DS, Millar MR. Differential expression of oestrogen receptor alpha and beta proteins in the testes and male reproductive system of human and non-human primates. Mol Hum Reprod 2001;7:227-36.
13. Muramatsu M, Inoue S. Estrogen receptors: How do they control reproductive and nonreporductive functions? Biochem Biophys Res Commun 2000;270:1-10.
14. Ascenzi P, Bocedi A, Marino M. Structure-function relationship of estrogen receptor alpha and beta: Impact on human health. Mol Aspects Med 2006;27:299-402.
15. Molla MDJ, Hidalgo-Mora JJ, Soteras MG. Phytotherapy as alternative to hormone replacement therapy. Front Biosci 2011;S3:191-204.
16. Messina M. Soybean isoflavone exposure does not have feminizing effects on men: A critical examination of the clinical evidence. Fertil Steril 2010;97:2095-104.
17. Ricketts ML, Moore DD, Banz WJ, Mezei O, Shay NF. Molecular mechanisms of action of the soy isoflavones includes activation of promiscuous nuclear receptors. A review. J Nutr Biochem 2005;16:321-30.
18. Veldhuis JD, Sowers JR, Rogot AD, Klien FK, Miller N, Dufau ML. Pathophysiology of male hypogonadism associated with endogenous hyperestrogenism. N Engl J Med 1985;312:1371-5.
19. Finkelstein JS, O'Dea LS, Whitcomb RW, Crowley WF. Sex steroid control of gonadotropin secretion in the human male II effects of estradiol administration in normal and gonadotropin-releasing hormone-deficient men. J Clin Endocrinol Metab 1991;73:621-8.
20. Hayes FJ, Seminara SB, Decruz S, Boepple PA, Aromatase CWF. Inhibition in the human male reveals a hypothalamic site of estrogen feedback. J Clin Endocrinol Metab 2000;85:3027-35.
21. Weiser MJ, Handa RJ. Estrogen impairs glucocorticoid dependent feedback on the hypothalamic-pituitary-gonadal axis via estrogen receptor alpha within the hypothalamus. Neuroscience 2009;159:883-95.
22. Simpson ER, Zhao Y, Agarwal VR, Michael MD, Bulun SE, Hinshelwood MM, Crahm-Lorence S, Sun T, Fisher CR, Qin K, Mendelson CR. Aromatase expression in health and disease. Recent Prog Horm Res 1997;52:185-213.
23. Lorentzon M, Eriksson AL, Mellstrom D, Ohlsson C. The COMT val158met polymorphism is associated with peak BMD in men. J Bone Miner Res 2004;19:2005-11.
24. Orwoll E, Lambert L, Marshall LM, Phipps K, Blank J, Barrett-Connor E, Cauley J, Ensrud K, Cummings S. Testosterone and estradiol among older men. J Clin Endocrinol Metab 2006;91:1336-44.
25. Middle JG, Kane JW. Oestradiol assays: Fitness for purpose? Ann Clin Biochem 2009;46:441-56.
26. Ferrini RL, Barrett-Connor E. Sex hormones and age: A cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am J Epidemiol 1998;147:750-4.
27. Denti L, Pasolini G, Sanfelici L, Benedetti R, Cecchetti A, Ceda GP, Ablondi F, Valenti G. Aging-related decline of gonadal function in healthy men: Correlation with body composition and lipoproteins. J Am Geriatr Soc 2000;48:51-8.
28. Leifke E, Gorenoi V, Cichers C, Von Zur Muhlen A, Von Buren E, Brabant G. Age-related changes of serum sex hormones, insulin-like growth factor-1, and sex hormone binding globulin levels in men: Cross-sectional data from a healthy male cohort. Clin Endocrinol (Oxf) 2000;53:689-95.
29. Muller M, den Tonkelaar I, Thijssen JH, Grobbee DE, van der Schouw YT. Endogenous sex hormones in men aged 40-80 years. Eur J Endocrinol 2003;149:583-9.
30. Bjornerem A, Straume B, Midtby M, Fonnebo V, Sundsfjord J, Svartberg J, Acharya G, Oian P, Berntsen GK. Endogenous sex hormones in relation to age sex, lifestyle factors and chronic diseases in a general population: The Tromso study. J Clin Endocrinol Metab 2004;89:6039-47.
31. Vermeulen A, Kaufman JM, Goemaere S, van Pottelberg I. Estradiol in elderly men. Aging Male 2002;5:98-102.
32. Khosla S, Melton J, Atkinson EJ, O'Fallon WM. Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab 2001;86:3555-61.
33. Lorentzon M, Swanson C, Anderson N, Mellstron D, Ohlsson C. Free testosterone is a positive whereas free estradiol is a negative predictor of cortical bone size in young Swedish men: The GOOD Study. J Bone Miner Res 2005;20:1334-41.
34. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, McKinlay JB. Age trends in the level of serum testosterone and other hormones in middle-aged men: Longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 2002;87:589-98.
35. Vermeulen A, Goemaere S, Kaufman JM. Sex hormones, body composition and aging. Aging Male 1999;2:8-11.
36. Orwoll ES, Nielson CM, Labrie F, Barrett-Connor E, Cauley JA, Cummings SR, Ensrud K, Karlsson M, Lau E, Leung PC, Lunggren O, Mellström D, Patrick AL, Stefanick ML, Nakamura K, Yoshimura N, Zmuda J, Vandenput L, Ohlsson C; Osteoporotic Fractures in Men (MrOS) Research Group. Evidence for geographical and racial variation in serum sex steroid levels in older men. J Clin Endocrinol Metab 2010;95:E151-60.
37. Baron JA, Barrett J, Malenka D, Fischer E, Kniffin SW, Bubolz T, Tosteson T. Racial difference in fracture risk. Epidemiology 1994;5:42-7.
38. LeBlanc ES, Nielson CM, Marshall LM, Lapidus JA, Barrett-Connor E, Ensrud KE, Hoffman AL, Laughlin G, Ohlsson C, Orwoll ES. The effects of serum testosterone, estradiol, and sex hormone binding globulin levels in on fracture risk in older men. J Clin Endocrinol Metab 2009;94:3337-46.
39. Guise TA, Oefelein MG, Eastham JA, Cookson MS, Higano CS, Smith MR. Estrogenic side effects of androgen deprivation therapy. Rev Urol 2007;9:163-80.
40. Rochira V, Zirilli L, Madeo B, Aranda C, Caffagni G, Fabre B, Montangero VE, Roldan EJ, Maffei L, Carani C. Skeletal effects of long-term estrogen and testosterone replacement in a man with congenital aromatase deficiency evidences of a priming effect of estrogen for sex steroids action on bone. Bone 2007;40:1662-8.
41. Clarke BL, Khosla S. Androgens and bone. Steroids 2009;74:296-305.
42. Sader MA, Celermajer DS. Endothelial function, vascular reactivity and gender differences in the cardiovascular system. Cardiovasc Res 2002;53:597-604.
43. Pottelbergh IV, Braeckman L, De Bacquer DD, De Backer G, Kaufman JM. Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoportein profile in healthy middle-aged men. Atherosclerosis 2003;166:95-102.
44. Maffei L, Murata Y, Rochira V, Tubert G, Aranda C, Vazquez M, Clyne CD, Davis S, Simpson ER, Carani C. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: Effects of testosterone, alendronate, and estradiol treatment. J Clin Endocrinol Metab 2004;89:61-70.
45. Rochira V, Madeo B, Zirilli L, Caffagni G, Maffei L, Carani C. Oestrasiol replacement treatment and glucose homeostasis in two men with congenital aromatase deficiency: Evidence for a role of oestradiol and sex steroids imbalance on insulin sensitivity in men. Diabet Med 2007;24:1491-5.
46. Bonkoff H, Berges R. The evolving role of oestrogens and their receptors in the development and progression of prostate cancer. Eur Urol 2009;55:533-42.
47. Miwa Y, Kaneda T, Yokoyama O. Association between lower urinary tract symptoms and serum levels of sex hormones in men. Urology 2008;72:552-5.
48. Gann PH, Hennekens CH, Longcope C, Verhoek-Oftedahl W, Grodstein F, Stampfer MJ. A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia. Prostate 1995;26:40-9.
49. St Sauver JL, Jacobson DJ, Mgree ME, Girman CJ, Klee GC, Lieber MM, Jacobsen SJ. Associations between longitudinal changes in serum estrogen, testosterone, and bioavailable testosterone and changes in benign urologic outcomes. Am J Epidemiol 2011;173:787-96.
50. Wibowo E, Schellhammer P, Wassersug RJ. Role of estrogen in normal male function: Clinical implications for patients with prostate cancer on androgen deprivations therapy. J Urol 2011;185:17-23.
51. Hess RA. Estrogen in the adult male reproductive tract: A review. Reprod Biol Endocrinol 2003;1:52-62.
52. Albrecht ED, Lane MV, Marshall GR, Merchenthaler I, Simorangkir DR, Phol CR, Plant CR, Plant TM, Pepe GJ. Estrogen promotes germ cell and seminiferous tubule development in the baboon fetal testis. Biol Reprod 2009;81:406-14.
53. Crews D, Morgentaler A. Effects of intracranial implantation of oestradiol and dihydrotestosterone on the sexual behavior of the lizard, Anolis carolinensis. J Endocrinol 1979;82:373-81.
54. Cornil CA, Dalla C, Papadopoulou-Daifoti Z, Baillien M, Balthazart J. Estradiol rapidly activates male sexual behavior and affects brain monoamine levels in the quail brain. Behav Brain Res 2006;166:110-23.
55. Arteaga-Silva M, Márquez-Villanueva Y, Martínez-García R, Hernández-González M, Bonilla-Jaime H, Retana-Márquez S. Effects of hormonal replacement with androgens and estrogens on male sexual behavior and plasma levels of these steroids in gonadectomized golden hamsters. Physiol Behav 2005;85:571-80.
56. Sengelaub DR, Forger NG. The spinal nucleus of the bulbocavernosus: Firsts in androgen-dependent neural sex differences. Horm Behav 2008;53:596-612.
57. Christensen LW, Clemens LG. Intrahypothalamic implants of testosterone or estradiol and resumption of masculine sexual behavior in long-term castrated male rats. Endocrinology 1974;95:984-90.
58. Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P, Mark M. Effect of single and compound knockouts of estrogen receptors alpha(ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development 2000;127:4277-91.
59. Juntti SA, Tollkuhn J, Wu MV, Fraser EJ, Soderborg T, Tan S, Honda SI, Harada N, Shah NM. The androgen receptor governs the execution, but not programming of male sexual and territorial behaviors. Neuron 2010;66:260-72.
60. Srilatha B, Adaikan PG. Estrogen and phytoestrogen predispose to erectile dysfunction: Do ER-alpha and ER-beta in the cavernosum play a role? Urology 2004;63:382-6.
61. Moon DG, Sung DJ, Kim YS, Cheon J, Kim JJ. Bisphenol A inhibits penile erection via alteration of histology in the rabbit. Int J Impot Res 2001;13:309-16.
62. Pan L, Xia X, Feng Y, Jiang C, Huang Y. Exposure to the phytoestrogen daidzein attenuates apomorphine-induced penile erection concomitant with plasma testosterone level reduction in dose- and time-related manner in adult rats. Urology 2007;70:613-7.
63. Sierens JE, Sneddon SF, Collins F, Millar MR, Saunders PT. Estrogens in testis biology. Ann N Y Acad Sci 2005;1061:65-76.
64. Cavaco JEB, Laurentino SS, Barros A, Sousa M, Estrogen SS. Receptors α and β in human testis: Both isoforms are expressed. Syst Biol 2009;55:137-44.
65. Setchell BP, Cox JE. Secretion of free and conjugated steroids by the horse testis into lymph and venous blood. J Reprod Fertil Suppl 1982;32:123-7.
66. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994;331:1056-61.
67. Herrman BL, Saller B, Janssen OE, Gocke P, Brockish A, Sperling H, Mann K, Broeker M. Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene. J Clin Endocrinol Metab 2002;87:5476-84.
68. Gades NM, Jacobson DJ, McGree ME, St Sauver JL, Lieber MM, Nehra A, Girman CJ, Klee GG, Jacobsen SJ. The associations between serum sex hormones, erectile function, and sex drive: The Olmsted County Study of urinary symptoms and health status among men. J Sex Med 2008;5:2209-20.
69. Basar MM, Aydin G, Mert HC, Keles I, Caglayan O, Orkun S, Batislam E. Relationship between serum sex steroids and aging male symptoms score and International Index of Erectile Function. Urology 2005;66:597-601.
70. Ponholzer A, Plas E, Schatzl G, Jungwirth A, Madersbacher S. Association of DHEA-S and estradiol serum levels to symptoms of aging men. Aging Male 2002;5:233-8.
71. Mancini A, Milardi D, Bianchi A, Summaria V, De Marinis L. Increased estradiol levels in venous occlusive disorder: A possible functional mechanism of venous leakage. Int J Impot Res 2005;17:239-42.
72. Chambliss KL, Shaul PW. Estrogen modulation of endothelial nitric oxide synthase. Endocr Rev 2002;23:665-86.
73. Greco EA, Pili M, Bruzziches R, Corona G, Spera G, Aversa A. Testosterone: Estradiol ratio changes associated with long-term tadalafil administration: A pilot study. J Sex Med 2006;3:716-22.
74. Braunstein GD. Clinical practice. Gyenecomastia. N Engl J Med 2007;357:1229-37.
75. Dobs A, Darkes MJM. Incidence and management of gynecomastia in men treated for prostate cancer. J Urol 2006;174:1737-42.
76. Aucoin MW, Wassersug RJ. The sexuality and social performance of androgen-deprived (castrated) men throughout history: Implications for modern day cancer patients. Soc Sci Med 2006;63:3162-73.
77. Weinberger LE, Sreenivasan S, Garrick T, Osran H. The impact of surgical castration on sexual recidivism risk among sexually violent predatory offenders. J Am Acad Psychiatry Law 2005;33:16-26.
78. Greenstein A, Plymate SR, Katz PG. Visually stimulated erection in castrated men. J Urol 1995;153:650-2.
79. Bergman B, Damber JE, Littbrand B, Sjogren K, Tomic R. Sexual function in prostatic cancer patients treated with radiotherapy, orchiectomy or estrogens. Br J Urol 1984;56:64-9.
80. Bales GT, Chodak GW. A controlled trial of bicalutamide versus castration in patients with advanced prostate cancer. Urology 1996;47:38-43.
81. Tyrrell CJ, Kaisary AV, Iversen P, Anderson JB, Baert L, Tammela T, Chamberlain M, Webster A, Blackedge G. A randomized comparison of "Casodex" (bicalutamide) 150mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancer. Eur Urol 1998;33:447-56.
82. Bettocchi C, Palumbo F, Cormio L, Ditonno P, Battaglia M, Selvaggi FP. The effects of androgen depletion on human erectile function: A prospective study in male-to-female transsexuals. Int J Impot Res 2004;16:544-6.
83. Luisi M, Franchi F. Double-blind group comparative study of testosterone undecanoate and mesterolone in hypogonadal male patients. J Endocrinol Invest 1980;3:305-8.
84. Moreland RB. Is there a role of hypoxemia in penile fibrosis: A viewpoint presented to the Society for the Study of Impotence. Int J Impot Res 1998;10:113-20.
85. Bagatell CJ, Heiman JR, Rivier JE, Bremner WJ. Effects of endogenous testosterone and estradiol on sexual behavior in normal young men. J Clin Endocrinol Metab 1994;78:711-6.
86. Gooren LJ. Human male sexual functions do not require aromatization of testosterone: A study using tamoxifen, testolactone, and hihydrotestosterone. Arch Sex Behav 1985;14:539-48.
87. Serjeant GR, De Ceulaer K, Maude GH. Stilboestrol and stuttering priapism in homozygous sickle-cell disease. Lancet 1985;2:1274-6.
88. Shamloul R, El Nashaar A. Idiopathic stuttering priapism treated successfully with low-dose ethinyl estradiol: A single case report. J Sex Med 2005;2:732-4.
89. Nenonen H, Bjork C, Skjaerpe P-A, Giwercman A, Rylander L, Svartberg J, Giwercman YL. CAG repeat number is not inversely associated with androgen receptor activity in vitro. Mol Hum Reprod 2010;16:153-7.
90. Hammoud A, Gibson M, Hunt S, Adams TD, Carrell DT, Kolotkin RL, Meikle AW. Effect of Roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men. J Clin Endocrinol Metab 2009;94:1329-32.
91. Eriksson AL, Lorentzon M, Vandenput L, Labrie F, Lindersson M, Syvanen A, Orwoll ES, Cummings SR, Zmuda JM, Ljunggren O, Karlsson MK, Mellstrom D, Ohlsson C. Genetic variations in sex steroid-related genes as predictors of serum estrogen levels in men. J Clin Endocrinol Metab 2009;94:1033-41.
92. Czajka-Oraniec I, Zgliczynski W, Kurylowicz A, Mikula M, Ostrowsi J. Association between gynecomastia and aromatase (CYP19) polymorphisms. Eur J Endocrinol 2008;158:721-7.
93. Shozu M, Sebastian S, Takayama K, Hsu WT, Schultz RA, Neely K, Bryant M, Bulun SE. Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene. N Engl J Med 2003;348:1855-65.
94. Walter M, Gerhard U, Gerlach M, Weijers H-G, Boening J, Wiesbeck GA. Controlled study on the combined effect of alcohol and tobacco smoking on testosterone in alcohol-dependent men. Alcohol Alcohol 2007;42:19-23.
95. Murialdo G, Galimberti CA, Fonzi S, Manni R, Costelli P, Parodi C, Solinas GP, Amoretti G, Tartara A. Sex hormones and pituitary function in male epileptic patients with altered or normal sexuality. Epilepsia 1995;36:360-5.
96. Winters SJ, Loriaux DL, Sherins RJ. Studies on the role of sex steroids in the feedback control of gonadatropin concentrations in men. II. Use of the estrogen antagonist, clomiphene citrate. J Clin Endocrinol Metab 1979;48:222-7.
97. Allan CA, Strauss JG, Burger HG, Forbes EA, McLauchlan RI. Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men. J Clin Endocrinol Metab 2008;93:139-46.
98. Amory JK, Watts NB, Easley KA, Sutton PR, Anawalt BD, Matsumoto AM, Bremmer J, Tenover JL. Exogenous testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J Clin Endocrinol Metab 2004;89:503-10.
99. Chiang HS, Hwang TIS, Hsui YS, Lin YC, Chen HE, Chen GC, Liao CH. Transdermal testosterone gel increases serum testosterone levels in hypogonadal men in Taiwan with improvements in sexual function. Int J Impot Res 2007;19:411-7.
100. Reyes-Vallejo L, Lazarou S, Morgentaler A. Subjective sexual response to testosterone replacement therapy based on initial serum levels of total testosterone. J Sex Med 2007;4:1757-62.
101. Schubert M, Minnemann T, Hubler D, Rouskova D, Christoph A, Oettel M, Ernst M, Mellinger U, Krone W, Jockenhovel F. Intramuscular testosterone undecanoate: Pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism. J Clin Endocrinol Metab 2004;89:5429-34.
102. Loves S, Ruinemans-Koert J, de Boer H. Letrozole once a week normalizes serum testosterone in obesity-related male hypogonadism. Eur J Endocrinol 2008;158:741-7.
103. Burnett-Bowie AM, Roupeniean KC, Dere M, Lee H, Leder B. Effects of aromatase inhibition in hypogonadal older men: A randomized, double-blind, placebo controlled trial. Clin Endocrinol (Oxf) 2009;70:116-23.
104. Goldstein SR, Siddhanti S, Ciaccia AV, Plouffe L. A pharmacological review of selective oestrogen receptor modulators. Hum Reprod Update 2000;6:212-4.
105. Tan RS, Vasudevan D. Use of clomiphene citrate to reverse premature andropause secondary to steroid abuse. Fertil Steril 2003;79:203-5.
106. Shabsigh A, Kang Y, Shabsigh R, Gonzalez M, Liberson G, Fisch H, Goluboff E. Clomiphene citrate effects on testosterone/estrogen ratio in male hypogonadism. J Sex Med 2005;2:716-21.
107. Guay AT, Bansal S, Heatley GJ. Effect of raising endogenous testosterone levels in impotent men with secondary hypogonadism. Double blind placebo-controlled trial with clomiphene citrate. J Clin Endocrinol Metab 1995;80:3546-52.
108. Taylor F, Levine L. Clomiphene citrate and testosterone gel replacement therapy for male hypogonadism: Efficacy and treatment cost. J Sex Med 2010;7:269-76.
109. Miki Y, Suzuki T, Nagasaki S, Hata S, Akahira J, Sasano H. Comparative effects of raloxifine, tamoxifen and estradiol on human osteoblasts in vitro: Estrogen receptor dependent or independent pathways of raloxifine. J Steroid Biochem Mol Biol 2009;113:281-9.
110. Kadioglu TC. Oral tamoxifen citrate treatment is more effective in normogonadotropic patients who have follicle-stimulating hormone levels within the lower half of normal. Int Urol Nephrol 2009;41:773-6.
111. Lakshman KM, Kaplan B, Travison TG, Basarla S, Knapp PE, Singh AB, LaValley MP, Manzer NA, Bhasin S. The effects of injected testosterone dose and age on the conversion of testosterone to estradiol and dihydrotestosterone in young and older men. J Clin Endocrinol Metab 2010;95:3955-64.
112. Sih R, Morley JE, Kaiser FE, Perry HM, Ping P, Ross C. Testosterone replacement in older hypogonadal men: A 12-month randomized controlled trial. J Clin Endocrinol Metab 1997;82:1661-7.
113. Rhoden EL, Morgentaler A. Treatment of testosterone-induced gynecomastia with the aromatase inhibitor, anastrozole. Int J Impot Res 2004;16:95-7.
114. Herzog AG, Klien P, Jacobs AR. Testosterone versus testosterone in treating reproductive and sexual dysfunction in men with epilepsy and hypogonadism. Neurology 1998;50:782-4.
115. Herzog AG, Farina EL, Drislane FW, Schomer DL, Smithson SH, Fowler KM, Dworetzky BA, Bromfeld EB. A comparison of anastrozole and testosterone versus placebo and testosterone for treatment of sexual dysfunction in men with epilepsy and hypogonadism. Epilepsy Behav 2010;17:264-71.
116. Toone BK, Wheeler M, Nanjee M, Fenwick P, Grant R. Sex hormones, sexual activity and plasma anticonvulsant levels in male epileptics. J Neurol Neurosurg Psychiatry 1993;46:824-6.